BIOS BioPlus Acquisition Corporation

BioScrip, Inc. (Nasdaq: BIOS) today announced that it will present at the forthcoming Piper Jaffray 20th Annual Health Care Conference, to be held December 2-3, 2008, at the New York Palace in New York City. BioScrip's Chairman and Chief Executive Officer, Richard H. Friedman, and Stanley G. Rosenbaum, Executive Vice President and Chief Financial Officer will present Tuesday, December 2nd at 3:30 PM ET (Eastern Time). Investors may access the live audio web cast of BioScrip's presentation at the following link: http://www.corporate-ir.net/ireye/conflobby.zhtml?ticker=BIOS&item_id=2021194. The web cast replay of the presentation can also be accessed via the company�s website at www.bioscrip.com, under the Investors section. About BioScrip, Inc. BioScrip, Inc. (www.bioscrip.com) (Nasdaq: BIOS) is a specialty pharmaceutical healthcare organization that partners with patients, physicians, healthcare payors and pharmaceutical manufacturers to provide access to medications and management solutions to optimize outcomes for chronic and other complex healthcare conditions. Forward Looking Statements This press release may contain statements which constitute forward looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding the intent, belief or current expectations of the Company, its directors, or its officers with respect to the future operating performance of the Company and our success with respect to the integration and consolidation. Investors are cautioned that any such forward looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward looking statements as a result of various factors. Important factors that could cause such differences are described in the Company's periodic filings with the Securities and Exchange Commission.